PrEP: latest news

PrEP resources

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • 30 years on and still more to do to educate gay men about HIV prevention

    Thirty years after the discovery of virus, new research from NAT (National AIDS Trust) reveals that gay men are in the dark about new HIV prevention tools, with knowledge among 16-24 year olds particularly low.

    23 April 2014 | NAT press release
  • Singapore Doc: "I remember the very first patient to whom I prescribed PrEP"

    Many of my patients find it difficult to broach the topic of PrEP. Most of them share with me that they are worried about being judged. I try to assuage this by making the discussion factual, objective, scientific and professional.

    22 April 2014 | My PrEP Experience (blog)
  • Head Of Largest U.S. HIV/AIDS Health Care Organization Still Insists Truvada Is A “Party Drug”

    The leader of the nation’s largest community HIV/AIDS health care organization stands by sharp words he had for a drug that has been approved for its potential to prevent the transmission of HIV — comments that some doctors and activists say are “irresponsible” and even led to a petition demanding his resignation.

    22 April 2014 | Buzzfeed
  • Medi-Cal Drops Providing Condoms and HIV Testing As Conditions for Prescribing Truvada

    California’s Medi-Cal program has made it easier for low-income people to get access to Truvada, a drug believed to reduce the risk of contracting HIV, by eliminating requirements that those people be provided with condoms and be tested monthly for HIV and that their doctors seek Medi-Cal’s permission before writing a prescription.

    22 April 2014 | WEHO ville
  • Px Wire: Long-Acting Injectables

    In this issue, we review the research on long-acting injectable antiretrovirals for treatment in HIV-positive people and PrEP in HIV-negative people. The pathways for developing these products have key similarities as well as differences—and as the same drugs advance for treatment and PrEP, it will be key to communicate these.

    17 April 2014 | AVAC
  • Petition to Remove AHF's Michael Weinstein for "Party Drug" remark about PrEP

    A former model for one of the AIDS Healthcare Foundation (AHF)'s campaigns has set up an online petition demanding the resignation of Michael Weinstein, Chief Executive of AHF, after he described Truvada pre-exposure prophylaxis as a "party drug".

    16 April 2014 |
  • Op-Ed: The Danger in Calling PrEP a "Party Drug"

    Michael Lucas calls on the president of the AIDS Healthcare Foundation to be removed from his job for remarks about Truvada

    15 April 2014 | Out
  • Why Aren’t Gay Men On The Pill?

    If we can get a critical mass of gay men on either Truvada PrEP or retrovirals, we could soon reach a tipping point in which this virus could be wiped out in a generation.

    10 April 2014 | The Dish
  • Long-acting HIV drugs advanced to overcome adherence challenge

    If it proves effective, long-acting antiretroviral therapy would set up a new paradigm of monthly or quarterly injectable therapy for some patients. Long-acting drug formulations could solve one of the thorniest problems in HIV management - adherence.

    08 April 2014 | Nature Medicine
  • Gay Men Divided Over Use of HIV Prevention Drug

    It's the Truvada conundrum: A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay sex without using condoms.

    07 April 2014 | ABC News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.